Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/2005
03/24/2005US20050063943 Conjugated of hydroxyalkyl starch and an active agent
03/24/2005CA2538069A1 Effectors of innate immunity determination
03/24/2005CA2537217A1 Therapeutic binding molecules
03/23/2005EP1516932A1 Poxvirus with targeted infection specificity
03/23/2005EP1516881A2 Composition and method for modulating dendritic Cell-T cell interaction
03/23/2005EP1516877A1 Amine derivatives as protease inhibitors
03/23/2005EP1516876A1 Mediators of hedgehog signalling pathways, compositions and uses related thereto
03/23/2005EP1516627A1 Interferon-Gamma for the treatment of diseases associated with the NOD2 gene
03/23/2005EP1516597A1 Drug eluting stent
03/23/2005EP1516064A2 Methods of using 46828, a human acyl-coa synthetase
03/23/2005EP1516052A1 Immunomodulation using altered dendritic cells
03/23/2005EP1515987A2 Mutated hpv-16 e7 polypeptide, pharmaceutical composition comprising it and its preparation process
03/23/2005EP1515982A2 Compositions and methods for the therapy and diagnosis of prostate cancer
03/23/2005EP1515978A1 Sulfur-containing phospholipid derivatives
03/23/2005EP1515949A1 Mitotic kinesin inhibitors
03/23/2005EP1515942A1 Carboxamides derivatives
03/23/2005EP1515753A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
03/23/2005EP1515747A2 Immunogenic agent therapy using plasmapheresis or exchange transfusion
03/23/2005EP1515743A2 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis
03/23/2005EP1515736A1 Compositions against inflammatory processes
03/23/2005EP1515727A2 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents
03/23/2005EP1515716A2 Indole derivatives having anti-angiogenetic activity
03/23/2005EP1515710A1 Method of treating rosacea by topical application of a cyclohexane derivative
03/23/2005EP1345618B1 Chlorzoxazone for the treatment of psoriasis
03/23/2005EP0804613B1 Dap-2 tumor suppressor gene, protein encoded thereby and use of said gene and protein
03/23/2005CN1599867A Immunocytokines with modulated selectivity
03/23/2005CN1599755A Antibodies against caspase-8, their preparation and use
03/23/2005CN1599745A Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist
03/23/2005CN1599741A Thioether substituted imidazoquinolines
03/23/2005CN1599740A Amide substituted imidazopyridines
03/23/2005CN1599739A Sulfonamido substituted imidazopyridines
03/23/2005CN1599738A Urea substituted imidazopyridines
03/23/2005CN1599737A Ring fused pyrazole derivatives
03/23/2005CN1599734A 3, 4-di-substituted maleimide compounds as CXC-chemokine receptor antagonists
03/23/2005CN1599729A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/23/2005CN1599717A Cyclic diamine compounds having fused-ring groups
03/23/2005CN1599623A Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
03/23/2005CN1599619A Methods and compositions for treating dermal lesions
03/23/2005CN1599613A Combinations for the treatment of immunoinflammatory disorders
03/23/2005CN1599611A Piperazine derivatives for use as CCR-3 receptor antagonists in the treatment of asthma
03/23/2005CN1599610A Preparation of pharmaceutical salts of 4((z)-(4-bromophenyl)(ethoxyimino)methyl)-1'-((2, 4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1, 4'bipiperidine as ccr5-antagonists for the treatment of aid
03/23/2005CN1599609A Combination of a selective PDE4 inhibitor and an adrenergic beta-2 receptor agonist
03/23/2005CN1599607A Carbinols for the treatment of neuropathic dysfunction
03/23/2005CN1599602A Peroxisome proliferator activated receptor ligands and process for producing the same
03/23/2005CN1599564A Oral immunostimulation of mammals, birds, fish and reptiles from 1-4 linked ss-d-mannuronic acid
03/23/2005CN1597667A Quinazoline derivatives as angiogenesis inhibitors
03/23/2005CN1596979A Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit
03/23/2005CN1596953A Medicine for treating anaphylactic dermatosis
03/23/2005CN1596898A Biammonium glycyrrhizate powder-injection and its preparation method
03/23/2005CN1194002C Shortened-chain polynucleotide and process for the preparation thereof
03/23/2005CN1193791C Ordered molecualr presentation of antigens. method of preparation and use
03/23/2005CN1193787C Use of cordyceps sinensis
03/23/2005CN1193775C Medicine for treating atrophic arthritis, ankylosing sponylitis
03/23/2005CN1193761C Controllable release system of glucocorticoid and its preparation method
03/23/2005CN1193756C SGK2 and SGK3 used as diagnostic and therapeutic targets
03/23/2005CN1193746C Substituted nitrobenzene derimative for medicine and other use
03/22/2005US6870070 Hydrogenation, resoulution, alkylation, bromination, andcarboxamidation
03/22/2005US6870033 Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies
03/22/2005US6869975 Linked biaryl compounds
03/22/2005US6869973 Nitrosated and nitrosylated taxanes, compositions and methods of use
03/22/2005US6869960 Substituted with a quinolin-3-ylmethyl- group, e.g., 2,3-dihydro-1'-((2-oxo-1,2,3,4-tetrahydro-3-quinolinyl)-methyl)spiro(1H -indene-1,4'-piperidine)
03/22/2005US6869956 Such as 4-(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a) quinoxaline; kits; treating arthritis, psoriasis, inflammatory bowel disease, autoimmune diseases and neurodegenerative diseases among others
03/22/2005US6869955 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
03/22/2005US6869954 Water-soluble phenylpyridazine compounds and compositions containing the same
03/22/2005US6869952 Such as 4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo(2,1-f)(1,2,4)triazin-6-ol; for treament of cancer
03/22/2005US6869945 Antihistamines; respiratory system disorders; antiinflammatory agents
03/22/2005US6869607 Vaccine formulations
03/22/2005US6869605 Anticarcinogenic agents
03/17/2005WO2005023871A1 An agent for selective suppression disease-associated auto-reactive b-cells
03/17/2005WO2005023853A1 Protease-resistant seb variant and vaccine containing the same
03/17/2005WO2005023782A1 Substituted fused pyrimidine-4(3h)-one compound
03/17/2005WO2005023771A1 Chemokine receptor antagonist and medical use thereof
03/17/2005WO2005023307A1 External preparation for percutaneous administration containing nonsteroidal anti-inflammatory analgesic
03/17/2005WO2005023305A2 Modulating cell activity by using an agent that reduces the level of cholesterol within a cell
03/17/2005WO2005023254A1 Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid and its pharmaceutical compositions containing the same
03/17/2005WO2005023235A1 Benzyl alcohol derivatives or salts thereof
03/17/2005WO2005012543A3 Quantitative method for detecting yessotoxins in fish products based on the activation caused by the toxin in cellular phosphodiesterase and therapeutic usefulness of said activation
03/17/2005WO2005000820A3 4-cyanopyrazole-3-carboxamide derivatives preparation and application thereof as cb1 cannabinoid antagonists
03/17/2005WO2005000817A3 Diphenylpyridine derivatives, preparation and therapeutic application thereof
03/17/2005WO2004056868A3 Nf-hev compositions and methods of use
03/17/2005WO2004022729A8 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
03/17/2005WO2002050028A8 Substituted benzoindoles as spla2 inhibitors
03/17/2005US20050059815 Processes for the synthesis of 2'-O-substituted pyrimidines and oligomeric compounds therefrom
03/17/2005US20050059714 2-Cyclopropyl-4-(5-fluoro-2-methoxyphenyl)-4-methyl-1-(1H-pyrrolo[2,3-c]pyridin-2-yl)pentan-2-ol; treating diseases of inflammatory, allergic, or proliferative condition; type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumor
03/17/2005US20050059710 Diphenylamino ketone derivatives as MEK inhibitors
03/17/2005US20050059700 Reacting compunds such as 6-methyl-12-oxa-tricyclo[8.2.1.0]trideca-2,4,6-trien-11-ol with compounds such as 4-(2,6-dichloro-phenyl)-piperidine to produce (+-)-cis-1-methyl-7-[[4-(2,6-dichloro-phenyl)piperidin-1-yl)]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol
03/17/2005US20050059699 N-acylated lipophilic amino acid derivatives
03/17/2005US20050059686 Pyrrolopyrimidines as phosphodiesterase vII inhibitors
03/17/2005US20050059666 CCR5 antagonists useful for treating AIDS
03/17/2005US20050059665 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
03/17/2005US20050059657 Aminoisoxazole derivatives active as kinase inhibitors
03/17/2005US20050059626 Methods of preventing and treating viral infections using immunomodulatory polynucleotide sequences
03/17/2005US20050059625 Immunostimulatory nucleic acid molecules
03/17/2005US20050059589 Such as cutaneous, ocular, nasal and bronchial allergic disease; interleukins and tumor necrosis factor receptors; competitive binding
03/17/2005US20050059587 Use of a protein for the production of a medicament for stimulating the innate non-specific immune system
03/17/2005US20050059577 Glycosylphosphatidylinositol containing polypeptides
03/17/2005US20050059151 Compositions and methods for priming monocytic dendritic cells and t cells for th-1response
03/17/2005US20050059144 MHC class II antigen-presenting systems and methods for activating CD4+ T cells
03/17/2005US20050059121 Colony stimualting factor for use in animal vaccination and as nonspecific immunity stimulant; veterinary medicine
03/17/2005US20050059107 Method of selecting hla-dp4 ligands and the applications thereof
1 ... 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 ... 1172